HIT Consultant April 2, 2024
Fred Pennic

What You Should Know:

Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.

– Built in collaboration with Mayo Clinic, the AI allows U.S. healthcare providers to detect Low Ejection Fraction (LVEF), a crucial indicator of heart failure, in just 15 seconds using a standard Eko stethoscope during a routine physical exam.

Importance of Early Detection

The advancement in early detection signifies a major medical innovation for cardiovascular disease. In the US alone, over 6 million individuals struggle with heart failure, with half experiencing HFrEF, a condition where the heart cannot pump blood efficiently. Traditionally, diagnosing heart failure often relies on echocardiography, a tool unavailable in many...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Patient / Consumer, Physician, Provider, Technology
OpenAI CPO: ChatGPT to Become Agentic in 2025
Report: Anthropic’s Annualized Revenue Reaches $1.4 Billion
OpenAI Launches New Tools for Building AI Agents
AI And Platforms Challenge A Key Management Theory. Again.
Salesforce pledges to invest $1 billion in Singapore over five years in AI push

Share This Article